Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product revenue guidance in six months. Moderna shares fell 2% in ...

Moderna, Inc. (NASDAQ ... Overall, MRNA ranks 5th on our list of Goldman Sachs' top growth investors. While we acknowledge the potential of MRNA as an investment, our conviction lies in the ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

Wall Street’s top firms have been reluctant to criticize President Trump’s trade policy, but Goldman took it to a new level ...

Goldman Sachs Group Inc.’s executive pay proposal won majority support from shareholders despite criticism the bonuses were ...

In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

Adamczyk joined Goldman Sachs in 2024 as advisory chairman of private investments and operations following a 16-year stint at ...